Mad about this
Really mad about this. I purposefully waited until near when the should have been reporting out. They probably should have been reporting results next week based on when they completed the trial enrollment. Now they extend it a month out of the blue. They dont tell us how many patients they added (maybe just one) and there was no safety issue they had to overcome. This makes no sense to me. Management just pulled some mellarchy. Be surprised if the stock doesn’t get beat up. The only positive is that no SAEs. Normally the only reason I can think of to expand the patient amount, if even real, is to get better statistical odds because you are worried about statistical significance. This will be a mass market drug so size of population helps safety but the tiny numbers they would have added would not matter. Very annoyed with management. This is the kind of crap I associate with cydy not relief but now relief is suspect.